Contrast Media

Behind every image is a patient. We provide a comprehensive portfolio of contrast media to help meet patient and procedural needs across imaging modalities.

110m+

doses currently produced globally every year¹

30m

more iodinated contrast media doses to be delivered annually by 2025¹

4 cGMP

accredited contrast media production facilities globally

$385m

invested over the last decade to increase capacity²

CONTRAST MEDIA

GE HealthCare has a distinguished heritage of contrast media development, offering a comprehensive product range across modalities, with a range of concentrations and innovative packaging choices.

Beyond the scan

Beyond the scan

Active Pharmaceutical Ingredients investment

$80 million invested to expand production at our Lindesnes, Norway API facility.

Contrast media production investment

Opening of new €30m manufacturing line in Cork to increase contrast media supply.

Products

Focusing on precision medicine from injection to diagnosis. Each dose, each patient, improving every day. Explore our broad portfolio of contrast media products and solutions.

Visit Products

References

1. GE Healthcare Data on File: Planned Investment 2022
2. GE Healthcare Data on File: Contrast Media Demand; 2022
3. Dhaliwal et al. Int J Life Cycle Assess 2014; 19: 1965-73.
4. GE Healthcare Data on File: iodine-recycling program 2022

cGMP: Current Good Manufacturing Practice

JB00020NZ 02-2023

Thank you!

We received your request for assistance.

A GE Healthcare specialist will be reaching out shortly.

Something went wrong

We will check and get back.

Try Again

JB00020NZ July 2024